Anti-HER2 CAR-T cells Clinical Trials

1 actively recruiting trial

Top Sponsors

UTC Therapeutics Inc.1

Indications

HER2-positive Advanced Malignant Solid Tumors1
Cancer1

Other1 trial

Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.